Latissimus Dorsi Strengthening Exercises in Rotator Cuff Tendinopathy
Effects of Latissimus Dorsi Exercises on Acromiohumeral Interval, Pain, and Function in Rotator Cuff Tendinopathy
1 other identifier
interventional
47
1 country
1
Brief Summary
The aim of this study is to investigate the effects of strengthening exercises targeting the latissimus dorsi muscle on acromiohumeral distance, shoulder function, and pain levels in individuals with rotator cuff tendinopathy. By increasing the activation of the latissimus dorsi, one of the shoulder adductor muscles, the exercises are expected to facilitate inferior gliding of the humeral head and improve subacromial distance. Individuals aged between 18 and 50 years with a diagnosis of rotator cuff tendinopathy will be included in the study. A total of 47 participants will be enrolled and randomly assigned to one of three groups: A group performing exercises targeting only the rotator cuff muscles, A group performing exercises targeting the latissimus dorsi muscle, A group performing a combination of both rotator cuff and latissimus dorsi exercises. The exercise interventions will be applied over a 12-week period. Before and after the intervention, the following outcomes will be assessed: Acromiohumeral distance (via ultrasound), Range of motion, Shoulder function and pain using the SPADI and WORC questionnaires, and Avoidance behavior using the Adap-Tr questionnaire.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 23, 2025
CompletedFirst Submitted
Initial submission to the registry
June 18, 2025
CompletedFirst Posted
Study publicly available on registry
July 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 22, 2027
September 15, 2025
June 1, 2025
2 years
June 18, 2025
September 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acromio-humeral distance
The acromiohumeral distance will be assessed using ultrasonography. Measurements will be performed by a physician blinded to the participants' group assignments, ensuring assessor blinding. Ultrasonographic measurement of the acromiohumeral distance has been shown to be reliable (intraclass correlation coefficient \> 0.90), and the minimal detectable change has been reported as 1.2 mm
Measurements will be performed at baseline and at the end of the 12th week
Pain İntensity
Pain intensity will be assessed using the Visual Analog Scale (VAS) at rest, during activity, and at night. On the VAS, a score of 0 indicates no pain, while a score of 10 represents unbearable pain. Higher scores reflect greater pain intensity.he scale will be explained to the patient in a face-to-face setting, and they will be asked to mark their pain levels at rest, during activity, and at night on a 100-millimeter horizontal line.
Baseline and weekly up to 12 weeks
Shoulder Range of Motion
ll measurements will be performed with the patient in the supine position. For shoulder flexion ROM, the patient will be asked to raise their arm upward in the sagittal plane. For shoulder abduction ROM, the patient will be instructed to move their arm laterally in the scapular plane.For external and internal rotation ROM measurements, the shoulder will be positioned at 90° of abduction and the elbow at 90° of flexion.For external rotation, the patient will be asked to move the forearm upward in the sagittal plane, with the palm facing toward themselves and in the direction of the thumb. For internal rotation, the patient will be asked to move the forearm downward in the sagittal plane, in the direction of the index finger.
Baseline and weekly up to 12 weeks
Secondary Outcomes (3)
ADAP-Shoulder Scale (Avoidance Behavior)
Measurements will be performed at baseline and at the end of the 12th week.
Shoulder Pain and Disability Index (SPADI)
At baseline and at the end of Week 12
Western Ontario Rotator Cuff Index (WORC)
Measurements will be performed at baseline and at the end of the 12th week.
Study Arms (3)
Rotator Cuff Exercise Group (RCEG)
EXPERIMENTALProgressive strengthening program for rotator cuff muscles.
Latissimus Dorsi Exercise Group (LDEG)
EXPERIMENTALProgressive strengthening program for latissimus dorsi muscle.
Combined Exercise Group (CEG)
EXPERIMENTALCombined strengthening program for rotator cuff and latissimus dorsi muscles
Interventions
Progressive exercise program focused on rotator cuff muscles
Progressive exercise program targeting the latissimus dorsi muscle
Eligibility Criteria
You may qualify if:
- Age between 18 and 50 years
- At least 3 months of ongoing shoulder pain
- At least 3 positive tests out of 5 (Neer, Hawkins-Kennedy, Jobe, Painful Arc Sign, Pain on Resisted External Rotation)
- Ultrasound diagnosis of rotator cuff tendinopathy
- Shoulder pain during activity rated greater than 3 out of 10 on the Numeric Pain Scale
- Central Sensitization Inventory score below 40
You may not qualify if:
- Bilateral shoulder pain
- History of surgery or dislocation in the symptomatic shoulder
- Acromioclavicular degeneration
- Presence of shoulder capsulitis (restriction in passive glenohumeral range of motion in 2 or more directions)
- Full-thickness rotator cuff tear
- Shoulder osteoarthritis, rheumatoid arthritis, systemic inflammatory or neurological disease
- Any injection to the symptomatic shoulder within the past 6 weeks
- BMI greater than 30 kg/m2
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Ankara, 06000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- In this study, both the participants and the investigator (physician) are blinded to the group assignments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Principal Investigator
Study Record Dates
First Submitted
June 18, 2025
First Posted
July 8, 2025
Study Start
May 23, 2025
Primary Completion (Estimated)
May 22, 2027
Study Completion (Estimated)
September 22, 2027
Last Updated
September 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to privacy and ethical considerations.